An infusion of cash makes this stock the hottest stock in
An infusion of cash makes this stock the hottest stock in the BIO market over night. It's like watching water boil...literally.
REMINDER OF WHAT IS REALLY GOING ON:
IPIX has worked tirelessly for years to bring drugs to the clinic. They have done so in a responsible and professional way. They have never failed and only succeeded. The results have been phenomenal over all fronts. DO NOT TAKE THAT FOR GRANTED. Shorts/Bears are doing everything they can to manipulate and create uncertainty about the data. It is not true and read Dr. B's and Leo's PR's and reports. We are in MANY multi BILLION markets with great unmet medical need. The best place one can be! Results do not have to be OVER THE MOON, they just have to be better or as good or safer than what is out there now! Just read what is going on with P data on liehub.......it is all BS!
IPIX has almost if not more than 20 CDA's which is not an easy accomplishment. This is something again people just write off! It is a serious accomplishment and MGMT has been entertaining and attending many many many private meetings and many have advanced to a late stage meeting where actual term sheets have been possibly written. Now is the time where MGMT go back around the room and listen to better offers and also express what others are wiling to pay and then again will go around the room for a better offer. This takes so much time in the real world.
IPIX has set the stage with several drugs knocking at the phase 3 door and all bring a great background of data and also bring a great variety of designations to further support the quality. I am not a pumper nor know any real pumpers for IPIX, I am a longterm investor that holds more hope in the drugs to help human kind than am hoping to make 10 million dollars.
I know our time will come and it's really hard right now to watch these disgusting financial terrorists just go to town on us and our hard earned investment, but we will have the last laugh with Leo and Dr. M and Dr. B.
I did confirm with a high level executive at AbbVie that a small bio's 'SHAREPRICE" has little effect on a BP's decision to partner or price or offer. Now please note the conversation was very indepth and went in many directions, so one of the topics was the question of how many drugs, or how many indications per drug, or what type of indication, is it unmet medical need, etc... How many CDA's? The discussion went on and covered a whole bunch of topics but as I explained IPIX, and he understood the company...he expressed that if IPIX is smart they move diligently and stealth - light footed I think he said while the mix of BP's - BIO's sort through the process and offers and paperwork. it takes time and sometimes alot of time. But, IPIX has had CDA's for quite some time and have been talking about it for years so I think we are close IMO. BP goes in with the understanding of market potential including competitors and risk. For B-OM - it really is SKY HIGH - wild wild west...... Alot of money to be made in the GOLD RUSH era and we are dead smack in the middle. Prurisol could also be that with it being a previously approved drug and very safe and ORAL.
GOOD TIMES COMING FRIENDS> Patience.
21
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...
Continue Reading
Glo Taps Top Wellness Expert for Women's Health Initiative In an industry brimming with wellness voices, it's rare to find one that marries scholarly acumen with authentic, personal teaching. Yet, this is precisely what Dr. Desi Bartlett brings to the table as she partners with Glo to offer new fitness programming specifically targeting women facing perimenopause and...
Continue Reading
Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...
Continue Reading
Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...
Continue Reading
When Maesa pulls back the curtain, they don't just crack it open—they fling it aside with flair. That's precisely what they're doing with their latest venture, Anecdotes by Artists, a fragrance brand that's taking its first bow exclusively at Sephora. It's not your average perfume launch; it's about the stories behind the scents and the artists who craft them. Unveiling...
Continue Reading
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...
Continue Reading
Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...
Continue Reading
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
America's New Obsession: Convenience at a Cost Diving into the relentless hustle, Americans are shelling out big bucks to dodge life's mundane chores. A fresh survey dished out by FinanceBuzz, hitching a ride with Bank of America, gives us a peek into how hooked everyone is on convenience services like food and grocery deliveries. It’s clear people are ready to fork...
Continue Reading
Top 5 Most Recently Viewed Articles
EMP Metals Reports Updated Resource Estimate EMP Metals Corp. (CSE: EMPS, OTCQB: EMPPF) is thrilled to share an updated Technical Report detailing the resource estimates for its Viewfield and Mansur lithium brine projects. This comprehensive report showcases a remarkable increase in the total resource, significantly boosting both the indicated and inferred lithium...
Continue Reading
Veriff Celebrates Trust Awards for Outstanding Innovators Today, Veriff, a leader in AI-driven identity verification, proudly recognized the first annual Veriff Trust Awards winners. This celebration highlights companies and individuals making significant strides towards enhancing trust in the online space and contributing to a safer internet. Rising Threats in Online...
Continue Reading
BitFuFu Reports Robust Financial Results for Q2 2025 BitFuFu Inc. (NASDAQ: FUFU), a leading innovator in Bitcoin mining services, recently shared its impressive financial performance for the second quarter of 2025, recording significant growth in revenues and net income. Financial Highlights from Q2 2025 For the quarter ended June 30, 2025, BitFuFu achieved year-over-year...
Continue Reading
Pivot Bio Strengthens Leadership with New Board Member New director brings rich agriculture and fertilizer experience to the forefront of innovation Pivot Bio, recognized for its groundbreaking advancements in the agricultural technology sector, has appointed Melih Keyman to its Board of Directors. This strategic move is expected to bolster the company's growth and...
Continue Reading
Significant Discoveries at the Saruman Project Midland Exploration Inc. (TSX-V: MD) is excited to announce the identification of copper-gold-molybdenum-silver occurrences on its Saruman project. This project, located in a region characterized by potential mineral wealth, consists of 121 claims covering an area of 64 square kilometers, which Midland acquired through map...
Continue Reading